United States · FDA National Drug Code directory
DILTIAZEM HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1335_f2a0ac76-9d93-eaad-e053-2a95a90a4d67
- Product NDC
- 51662-1335
- Form
- INJECTION
- Composition / generic term
- DILTIAZEM HCI
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181221
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL (51662-1335-1) · 51662-1335-1
- 1 VIAL in 1 POUCH (51662-1335-2) / 5 mL in 1 VIAL · 51662-1335-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →